ERbeta/ERalpha ratio may even affect the estrogen-mediated growth stimulation and then reduce cytotoxicity at physiological concentrations that may possess some clinical implications for pancreatic cancer therapy [40]. This evidence concerns the gene ESR1 and pancreatic neoplasm.